Start Date
November 30, 2015
Primary Completion Date
November 30, 2017
Study Completion Date
January 1, 2020
Liposomal bupivacaine
Liposomal bupivacaine (EXPAREL®) 133 mg in 10 mL for quadriceps sparing femoral nerve block and 133 mg in 20 mL for posterior knee compartment periarticular injection.
Bupivacaine plus dexamethasone
Bupivacaine HCl 0.5% 10 mL plus dexamethasone 2 mg for quadriceps sparing femoral nerve block and bupivacaine HCl 0.25% plus dexamethasone 2 mg for posterior knee compartment periarticular injection
Albany Medical Center, Albany
Lead Sponsor
Albany Medical College
OTHER